Leading the Way in Life Science Technologies

GEN Exclusives

More »

GEN News Highlights

More »
March 3, 2010

GSK to Use Gentronix’ GreenScreen HC and BlueScreen HC Genotoxicity Assays

  • Gentronix entered into a three-year agreement to provide GlaxoSmithKline (GSK) with GreenScreen HC and BlueScreen HC genotoxicity assays. The reporter-based assays have demonstrated the ability to detect known classes of genotoxic agent and utilize Green Fluorescent Protein or Gaussia Luciferase to detect GADD-45a upregulation, which is a key indicator of DNA damage.

    GreenScreen HC is a human cell-based assay technology that combines high sensitivity for detecting genotoxic chemicals with high specificity for reducing false positive results, Gentronix notes. BlueScreen HC is the new luciferase-based assay that combines all the attributes of GreenScreen HC with the ability to be run in a 384-well microtiter plate format.

Related content

  • Finally! A cure for the Biotech News Blues.

  • Join 110,000 colleagues who rely on GEN Highlights for breaking news and exclusive articles shaping today’s life science tools and technologies.

  • Oops! Please type your email in the following format: yourname@example.com An error has occurred. Please contact Customer Service at contactGEN@genengnews.com
  • You’re all set! Thank you for subscribing to GEN Highlights.